Study of ONO-4538 in Gastric Cancer

NCT02746796 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

680

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: ONO-4538
DRUG: Oxaliplatin
DRUG: Tegafur- Gimeracil-Oteracil potassium
DRUG: Capecitabine
DRUG: Placebo

Sponsor

Ono Pharmaceutical Co., Ltd.